Home / Daily News / Erratic Behavior Ahead? Stock Update on Genesis Healthcare, Inc. (NYSE:GEN)

 

Taking a look at valuation rankings for Genesis Healthcare, Inc. (NYSE:GEN), we see that the stock has a Value Composite score of 49. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 59.

Investors are usually trying to figure out the best strategy to use when tackling the equity market. Because there is no one perfect method for picking winning stocks, investors may have to try various techniques before they get it right. There are many different factors that can affect the financial health of a company, and this makes it hard to concoct a formula that works well across the board. Studying all the data can help with investing decisions, but it is typically more important to be focusing on the right information. Knowing exactly what data should be studied may only come by logging many hours of research. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow. The FCF Growth of Genesis Healthcare, Inc. (NYSE:GEN) is -1.200768. Free cash flow (FCF) is the cash produced by the company minus capital expenditure. This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends. The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow. The FCF Score of Genesis Healthcare, Inc. (NYSE:GEN) is 1.602285. Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Genesis Healthcare, Inc. (NYSE:GEN) for last month was 0.84034. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Genesis Healthcare, Inc. (NYSE:GEN) is 0.66667.

The EBITDA Yield is a great way to determine a company’s profitability.  This number is calculated by dividing a company’s earnings before interest, taxes, depreciation and amortization by the company’s enterprise value.  Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents.  The EBITDA Yield for Genesis Healthcare, Inc. (NYSE:GEN) is 0.070860. 

C-Score Montier

Genesis Healthcare, Inc. (NYSE:GEN) currently has a Montier C-score of 1.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

After a recent scan, we can see that Genesis Healthcare, Inc. (NYSE:GEN) has a Shareholder Yield of -0.055290 and a Shareholder Yield (Mebane Faber) of 6.38044. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.

Genesis Healthcare, Inc. (NYSE:GEN) has a current MF Rank of 9877. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

The M-Score, conceived by accounting professor Messod Beneish, is a model for detecting whether a company has manipulated their earnings numbers or not. Genesis Healthcare, Inc. (NYSE:GEN) has an M-Score of -2.931692.  The M-Score is based on 8 different variables: Days’ sales in receivables index, Gross Margin Index, Asset Quality Index, Sales Growth Index, Depreciation Index, Sales, General and Administrative expenses Index, Leverage Index and Total Accruals to Total Assets.  A score higher than -1.78 is an indicator that the company might be manipulating their numbers.

Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks.  The Price Range of Genesis Healthcare, Inc. (NYSE:GEN) over the past 52 weeks is 0.565000.  The 52-week range can be found in the stock’s quote summary.

When doing stock research, there is plenty of easily measureable data regarding publically traded companies. There is also plenty of information that is not easily measured such as competitive advantage, quality of staff, and company reputation. Because there are forces such as the human element that come into play when selecting stocks, prices may not always move as expected. Even after crunching all the numbers and digging deep into a specific company, the stock’s performance still might not match expectations. Investors may realize that sometimes perception can be more powerful than reality. Human emotions can change very rapidly, and so can the prevailing market sentiment as well.

 
Share this page